AIP
INBX

Ameritas Investment Partners’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Ameritas Investment Partners’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,412
Closed -$119K – 3309
2024
Q1 		$119K Hold
3,412
– – ﹤0.01% 1626
2023
Q4 		$130K Hold
3,412
– – ﹤0.01% 1563
2023
Q3 		$62.6K Buy
3,412
+805
+31% +$16.8K ﹤0.01% 1962
2023
Q2 		$67.7K Hold
2,607
– – ﹤0.01% 1854
2023
Q1 		$49.2K Hold
2,607
– – ﹤0.01% 1993
2022
Q4 		$66.3K Buy
2,607
+418
+19% +$12.3K ﹤0.01% 1871
2022
Q3 		$39K Hold
2,189
– – ﹤0.01% 2164
2022
Q2 		$24K Hold
2,189
– – ﹤0.01% 2481
2022
Q1 		$49K Hold
2,189
– – ﹤0.01% 2076
2021
Q4 		$96K Hold
2,189
– – ﹤0.01% 1707
2021
Q3 		$73K Hold
2,189
– – ﹤0.01% 1900
2021
Q2 		$60K Buy
2,189
+1,508
+221% +$31.4K ﹤0.01% 2072
2021
Q1 		$14K Hold
681
– – ﹤0.01% 2733
2020
Q4 		$22K Buy
+681
New +$18.1K ﹤0.01% 2436

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Ameritas Investment Partners's INBX Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 3,412 shares — an estimated $119K sold.

Ameritas Investment Partners first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $130K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,412 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $119K.
  • Ameritas Investment Partners first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Ameritas Investment Partners's Inhibrx, Inc. Common Stock position peaked at $130K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.